A unique program in Madhya Pradesh connects blood donation with VIP darshan at Omkareshwar Jyotirlinga temple. Devotees donating blood rece...

A new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...

Chinese intelligence is now using professional networking sites and job portals to find and recruit people with access to sensitive data. T...

As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

Quote of the day by Princess Diana highlights the value of family, relationships, love, peace, and emotional support. Princess Diana believ...

US-Iran war: Tehran has rejected remarks by US Secretary of State Marco Rubio. Iran states US sanctions have held the global energy market ...

US Vice President JD Vance announced a significant deferral of federal Medicaid funds to California. The government is withholding $1.3 bil...

Eli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...

Eli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...

An 800-year-old Chinese exercise once practiced quietly in parks and public squares is now drawing global attention after scientists discov...

A groundbreaking study published in Nature Medicine reveals that the experimental drug Elraglusib, when combined with standard chemotherapy...

A scientific breakthrough offers a new way to produce vitamin B12. Researchers are using managed light on Spirulina, a blue-green algae. Th...

The soccer coach had blocked himself from sportsbooks by the time he found prediction markets.

Cannabis decision by the Federal Government Iargely legitimizes medical marijuana programs in the 40 states that have adopted them.

India's economic growth is increasingly driven by disciplined MSMEs, not just startups. Stanford Seed's Harish Arnezath highlights that fou...

Drug maker Sun Pharmaceuticals launched Imatinib Mesylate, the generic copy of anti-cancer drug Gleevec, in the US market enjoying 180 days...

Today’s Supreme Court judgment on the Glivec case means that innovator companies like Novartis will see little protection for intellectual ...